Shi Helen, Bobanga Iulianna, McHenry Christopher R
Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA; Department of Surgery, University Hospitals Case Medical Center, Cleveland, OH, 44106, USA.
Am J Surg. 2017 Mar;213(3):464-466. doi: 10.1016/j.amjsurg.2016.10.028. Epub 2016 Dec 28.
Our aim was to investigate whether benign thyroid nodules ≥ 4 cm have a higher malignancy rate.
A retrospective review of patients with a nodule and a benign FNAB who underwent thyroidectomy was completed. Patients were divided into two groups; nodule size: < 4 cm or ≥4 cm, and clinical factors, nodule size and rates of malignancy were compared.
337 patients underwent thyroidectomy: 99 had nodules <4 cm (2.8 ± 0.58 cm) and 238 had nodules ≥ 4 cm (5.9 ± 1.97 cm). Seven (2.1%) patients had cancer, 2 (2.0%) with a nodule < 4 cm and 5 (2.1%) with a nodule ≥ 4 cm (p = 0.962). There was no difference in clinical factors between groups (p > 0.05).
There is no difference in rates of malignancy for nodules < 4 cm or ≥ 4 cm. Thus, thyroidectomy should not be recommended based solely on nodule size.
我们的目的是研究直径≥4 cm的甲状腺良性结节是否具有更高的恶性率。
对接受甲状腺切除术的有结节且细针穿刺活检(FNAB)结果为良性的患者进行回顾性研究。患者分为两组;结节大小:<4 cm或≥4 cm,并比较临床因素、结节大小和恶性率。
337例患者接受了甲状腺切除术:99例患者的结节<4 cm(2.8±0.58 cm),238例患者的结节≥4 cm(5.9±1.97 cm)。7例(2.1%)患者患有癌症,2例(2.0%)结节<4 cm,5例(2.1%)结节≥4 cm(p = 0.962)。两组之间的临床因素无差异(p>0.05)。
直径<4 cm或≥4 cm的结节的恶性率无差异。因此,不应仅基于结节大小就建议进行甲状腺切除术。